Clinical practice guidelines for the prevention and diagnosis of lung cancer

Cite this guideline

Cancer Council Australia Lung Cancer Prevention and Diagnosis Guidelines Working Party. Clinical practice guidelines for the prevention and diagnosis of lung cancer. Sydney: Cancer Council Australia. [Version URL: https://wiki.cancer.org.au/australiawiki/index.php?oldid=213466, cited 2023 Dec 7]. Available from: https://wiki.cancer.org.au/australia/Guidelines:Lung_cancer/Prevention_and_diagnosis.

Please note there are further questions under development for this guideline and they will be released for public consultation and published in a staged approach. To be notified about updates, please email guidelines (at) cancer.org.au.

See also: Clinical practice guidelines for the treatment of lung cancer.

Clinical practice guidelines for the prevention and diagnosis of lung cancer

Foreword

Summary of recommendations (published content)

Screening and early detection

• In people at risk of lung cancer, does population based screening with chest radiography reduce mortality?

• CT screening

• In people at risk of lung cancer, does population based CT screening reduce mortality?

• Which population group would potentially most benefit from CT screening for lung cancer?

Diagnosis and staging

• When is IHC required for subtyping of NSCLC and what is the optimal IHC panel?

• What specimen types are suitable for mutation testing in NSCLC patients?

• In people undergoing lung cancer evaluation, does concurrent diagnosis and staging provide greater benefit for patient outcomes compared to sequential testing for diagnosis followed by staging?

• For patients undergoing workup for known or suspected lung cancer, what is the optimal timing of PET/CT? Before or after tissue biopsy confirmation?

Follow up

• Does routine follow-up improve patient outcomes in people who have curative intent treatments for lung cancer?

• What are the optimal follow-up tests for people with lung cancer who have had curative intent treatment?

• What is the optimal model (provider) of care for the follow up of people with lung cancer who have had curative intent treatment?

Questions under development

• What is the most effective way to manage small solid, sub-solid and non-solid nodules?
• For suspected lung cancer in the periphery of the lung (peripheral pulmonary lesions), what is the most effective diagnostic modality?

Appendices

• Guideline development process
• List of clinical questions
• Working party members and contributors
• Conflict of interest register

Further information for health professionals

Investigating symptoms of lung cancer: a guide for all health professionals

Information for consumers

Understanding Lung Cancer

Back to top